β‐Cyclodextrin Derivatives, SBE4‐β‐CD and HP–β‐CD, Increase the Oral Bioavailability of Cinnarizine in Beagle Dogs
- 1 March 1995
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 84 (3), 295-299
- https://doi.org/10.1002/jps.2600840306
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Medicinal Applications of CyclodextrinsMedicinal Research Reviews, 1994
- Cyclodextrins in the Pharmaceutical FieldDrug Development and Industrial Pharmacy, 1991
- Application of Gastric Acidity-Controlled Beagle Dog to Bioavailability Study of CinnarizineYAKUGAKU ZASSHI, 1990
- Enhancement of the Oral Bioavailability of Cinnarizine in Oleic Acid in Beagle DogsJournal of Pharmaceutical Sciences, 1987
- Gastric acidity dependent bioavailability of cinnarizine from two commercial capsules in healthy volunteersInternational Journal of Pharmaceutics, 1986
- Evaluation of beagle dogs as an animal model for bioavailability testing of cinnarizine capsulesInternational Journal of Pharmaceutics, 1986
- Kinetics of degradation of cinnarizine in aqueous solution.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Evaluation of bioavailability upon oral administration of cinnarizine-.BETA.-cyclodextrin inclusion complex to beagle dogs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Inclusion complexes of cinnarizine with .BETA.-cyclodextrin in aqueous solution and in the solid state.CHEMICAL & PHARMACEUTICAL BULLETIN, 1984
- Determination of Ionization Constants in Mixed Aqueous Solvents of Varying Composition by a Single TitrationJournal of Pharmaceutical Sciences, 1978